KTTA · Pasithea Therapeutics Corp.

Summary

Pasithea Therapeutics Corp. disclosed under Item 3.01 on February 20, 2026, a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This indicates potential non-compliance with exchange listing requirements.

Key takeaways

• Item 3.01 disclosure on February 20, 2026
• Notice of delisting or failure to satisfy continued listing rule or standard
• Possible transfer of listing
• Pasithea Therapeutics Corp. (KTTA)